These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9411660)

  • 1. [Alcoholism: relapse prevention].
    Pelc I
    Rev Med Brux; 1997 Sep; 18(4):272-6. PubMed ID: 9411660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
    Soyka M; Preuss U; Schuetz C
    Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acamprosate in alcohol dependence: how does it work?
    Littleton J
    Addiction; 1995 Sep; 90(9):1179-88. PubMed ID: 7580816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological relapse prevention in alcohol and tobacco dependence].
    Diehl A; Mann K
    Internist (Berl); 2007 Jan; 48(1):79-84, 86-8. PubMed ID: 17122900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New drugs in the treatment of alcoholism].
    Besson J
    Schweiz Med Wochenschr; 1997 Sep; 127(38):1574-8. PubMed ID: 9411716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficient prevention of relapse with acamprosate].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2000 Jun; 23(6):206-7. PubMed ID: 10950666
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advances in the treatment of alcohol dependence: pharmacological relapse prevention].
    Smolka MN; Kiefer F; Mann K
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():65-9. PubMed ID: 15490769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study.
    Schädlich PK; Brecht JG
    Pharmacoeconomics; 1998 Jun; 13(6):719-30. PubMed ID: 10179707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome.
    Ansoms C; Deckers F; Lehert P; Pelc I; Potgieter A
    Eur Addict Res; 2000 Sep; 6(3):132-40. PubMed ID: 11060477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?
    De Wildt WA; Schippers GM; Van Den Brink W; Potgieter AS; Deckers F; Bets D
    Alcohol Alcohol; 2002; 37(4):375-82. PubMed ID: 12107041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological treatment of alcohol dependence: needs and possibilities.
    Mann K
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):55-8. PubMed ID: 9845038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
    Wilde MI; Wagstaff AJ
    Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acamprosate and psychosocial intervention. An integrative treatment approach for prevention of alcohol dependent patients in Switzerland].
    Fuchs WJ; Riebenfeld D
    Praxis (Bern 1994); 2002 Apr; 91(17):735-42. PubMed ID: 12038194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preventing recurrence after alcohol withdrawal treatment with drugs. Reducing the drive to drink].
    MMW Fortschr Med; 2003 May; 145(19):56. PubMed ID: 12813988
    [No Abstract]   [Full Text] [Related]  

  • 16. The current situation of treatment systems for alcoholism in Korea.
    Kim JW; Lee BC; Kang TC; Choi IG
    J Korean Med Sci; 2013 Feb; 28(2):181-9. PubMed ID: 23400047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acamprosate: recent findings and future research directions.
    Mann K; Kiefer F; Spanagel R; Littleton J
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1105-10. PubMed ID: 18540918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study.
    Mann K; Kiefer F; Smolka M; Gann H; Wellek S; Heinz A;
    Alcohol Clin Exp Res; 2009 Apr; 33(4):674-83. PubMed ID: 19170666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.
    Prescrire Int; 2009 Oct; 18(103):222-3. PubMed ID: 19882797
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.
    Kiefer F; Helwig H; Tarnaske T; Otte C; Jahn H; Wiedemann K
    Eur Addict Res; 2005; 11(2):83-91. PubMed ID: 15785069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.